Delivery Order SPE2DB22D2206-SPE2DB23FKN99
Award Date 9/26/23
Potential Completion Date 9/27/23
Potential Value $15K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of Biktarvy 50-200-25 mg tablets to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for $82,631.52. The contract has an ultimate completion date of April 28, 2023 and is a firm fixed-price delivery order with no set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite...
- This federal contract award is for the delivery of Biktarvy 50-200-25 mg tablets to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for a ceiling value of $183,381.50. The contract is a firm-fixed price delivery order with a completion date of February 23, 2023. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is for the delivery of Biktarvy 50-200-25 mg tablets to the Defense Logistics Agency (DLA), a component of the Department of Defense. The contract has a ceiling value of $10,728.19 and was awarded to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order with a firm fixed-price pricing type and has an ultimate completion date of March 7, 2024. There is no set-aside designation for this contract....
- This federal contract award is for the delivery of Biktarvy 50-200-25 mg tablets to the Defense Logistics Agency (DLA), a major Department of Defense (DoD) procurement agency. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., for a ceiling value of $12,937.53. The contract is a delivery order with a firm fixed price pricing type and an ultimate completion date of May 16, 2023. Amerisourcebergen Drug Corp is a prominent pharmaceutical...
- This federal contract award is for the delivery of Biktarvy 50-200-25 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $14,129.65 and an ultimate completion date of July 26, 2023. It is a delivery order contract with a firm fixed price pricing type. This award is not associated with a set-aside designation, indicating open competition....
- This federal contract award is for the delivery of Biktarvy 50-200-25 mg tablet, a pharmaceutical product, to the Defense Logistics Agency (DLA) Medical. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract has a ceiling value of $23,197.99 and is a delivery order with a firm fixed price type. The contract has an ultimate completion date of May 11, 2023, and was awarded on May 10, 2023. The contract is...
- This federal contract award is for the delivery of Biktarvy 50-200-25 mg tablets to the Defense Logistics Agency (DLA). The $7,633.73 firm-fixed-price delivery order was awarded to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has an ultimate completion date of November 7, 2023 and was not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award is for the delivery of Biktarvy 50-200-25 mg tablets to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The award, valued at $26,895.33, was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor that supplies a wide range of medical products to federal agencies, including the Department of Defense and Veterans Affairs healthcare systems. The contract is a delivery order placed under Amerisourcebergen's existing...
- This federal contract award is for the delivery of Biktarvy 50-200-25 mg tablets, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., on February 28, 2024, with a ceiling value of $66,742.91 and a completion date of February 29, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is part of a larger Indefinite Delivery Contract (IDC) held...
- This federal contract award is for the delivery of Biktarvy 50-200-25 mg tablets to the Defense Logistics Agency (DLA). The $4,759.11 firm-fixed-price delivery order was issued to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has an ultimate completion date of August 18, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that supplies medical products to federal government agencies,...